Large-Scale Screening of Per- and Polyfluoroalkyl Substance Binding Interactions and Their Mixtures with Nuclear Receptors

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2024 Aug 10

PMID 39125814

Authors

Saptarshi Roy

James Moran

Keerthana Danasekaran

Kate OBrien

Sivanesan Dakshanamurthy

Affiliations

Soon will be listed here.

Abstract

Despite their significant impact, comprehensive screenings and detailed analyses of per- and polyfluoroalkyl substance (PFAS) binding strengths at the orthosteric and allosteric sites of NRs are currently lacking. This study addresses this gap by focusing on the binding interaction analysis of both common and uncommon PFAS with the nuclear receptors (NRs) vitamin D receptor (VDR), peroxisome proliferator-activated receptor gamma (PPARγ), pregnane X receptor (PXR), and estrogen receptor alpha (ERα). Advanced docking simulations were used to screen 9507 PFAS chemicals at the orthosteric and allosteric sites of PPARγ, PXR, VDR, and ERα. All receptors exhibited strong binding interactions at the orthosteric and allosteric site with a significant number of PFAS. We verified the accuracy of the docking protocol through multiple docking controls and validations. A mixture modeling analysis indicates that PFAS can bind in various combinations with themselves and endogenous ligands simultaneously, to disrupt the endocrine system and cause carcinogenic responses. These findings reveal that PFAS can interfere with nuclear receptor activity by displacing endogenous or native ligands by binding to the orthosteric and allosteric sites. The purpose of this study is to explore the mechanisms through which PFAS exert their endocrine-disrupting effects, potentially leading to more targeted therapeutic strategies. Importantly, this study is the first to explore the binding of PFAS at allosteric sites and to model PFAS mixtures at nuclear receptors. Given the high concentration and persistence of PFAS in humans, this study further emphasizes the urgent need for further research into the carcinogenic mechanisms of PFAS and the development of therapeutic strategies that target nuclear receptors.

References

Khazaee M, Christie E, Cheng W, Michalsen M, Field J, Ng C . Perfluoroalkyl Acid Binding with Peroxisome Proliferator-Activated Receptors α, γ, and δ, and Fatty Acid Binding Proteins by Equilibrium Dialysis with a Comparison of Methods. Toxics. 2021; 9(3). PMC: 7996760. DOI: 10.3390/toxics9030045. View

Wan M, Co V, El-Nezami H . Endocrine disrupting chemicals and breast cancer: a systematic review of epidemiological studies. Crit Rev Food Sci Nutr. 2021; 62(24):6549-6576. DOI: 10.1080/10408398.2021.1903382. View

Azhagiya Singam E, Durkin K, La Merrill M, Furlow J, Wang J, Smith M . Prediction of the Interactions of a Large Number of Per- and Poly-Fluoroalkyl Substances with Ten Nuclear Receptors. Environ Sci Technol. 2024; 58(10):4487-4499. PMC: 10938639. DOI: 10.1021/acs.est.3c05974. View

Chang T . Activation of pregnane X receptor (PXR) and constitutive androstane receptor (CAR) by herbal medicines. AAPS J. 2009; 11(3):590-601. PMC: 2758128. DOI: 10.1208/s12248-009-9135-y. View

Jones R, Madrigal J, Troisi R, Surcel H, Ohman H, Kivela J . Maternal serum concentrations of per- and polyfluoroalkyl substances and childhood acute lymphoblastic leukemia. J Natl Cancer Inst. 2023; 116(5):728-736. PMC: 11077307. DOI: 10.1093/jnci/djad261. View

Ding N, Harlow S, Randolph Jr J, Loch-Caruso R, Park S . Perfluoroalkyl and polyfluoroalkyl substances (PFAS) and their effects on the ovary. Hum Reprod Update. 2020; 26(5):724-752. PMC: 7456353. DOI: 10.1093/humupd/dmaa018. View

Toporova L, Balaguer P . Nuclear receptors are the major targets of endocrine disrupting chemicals. Mol Cell Endocrinol. 2019; 502:110665. DOI: 10.1016/j.mce.2019.110665. View

Gim H, Choi Y, Li H, Kim Y, Ryu J, Jeon R . Identification of a Novel PPAR-γ Agonist through a Scaffold Tuning Approach. Int J Mol Sci. 2018; 19(10). PMC: 6213020. DOI: 10.3390/ijms19103032. View

Liang L, Pan Y, Bin L, Liu Y, Huang W, Li R . Immunotoxicity mechanisms of perfluorinated compounds PFOA and PFOS. Chemosphere. 2021; 291(Pt 2):132892. DOI: 10.1016/j.chemosphere.2021.132892. View

10.

Di Nisio A, Rocca M, De Toni L, Sabovic I, Guidolin D, DallAcqua S . Endocrine disruption of vitamin D activity by perfluoro-octanoic acid (PFOA). Sci Rep. 2020; 10(1):16789. PMC: 7545187. DOI: 10.1038/s41598-020-74026-8. View

11.

Kirk A, Michelsen-Correa S, Rosen C, Martin C, Blumberg B . PFAS and Potential Adverse Effects on Bone and Adipose Tissue Through Interactions With PPARγ. Endocrinology. 2021; 162(12). PMC: 9034324. DOI: 10.1210/endocr/bqab194. View

12.

von Holst H, Nayak P, Dembek Z, Buehler S, Echeverria D, Fallacara D . Perfluoroalkyl substances exposure and immunity, allergic response, infection, and asthma in children: review of epidemiologic studies. Heliyon. 2021; 7(10):e08160. PMC: 8529509. DOI: 10.1016/j.heliyon.2021.e08160. View

13.

Lin H, Feng H, Chen L, Yuan X, Tan Z . Maternal exposure to environmental endocrine disruptors during pregnancy is associated with pediatric germ cell tumors. Nagoya J Med Sci. 2020; 82(2):323-333. PMC: 7276419. DOI: 10.18999/nagjms.82.2.315. View

14.

Eberhardt J, Santos-Martins D, Tillack A, Forli S . AutoDock Vina 1.2.0: New Docking Methods, Expanded Force Field, and Python Bindings. J Chem Inf Model. 2021; 61(8):3891-3898. PMC: 10683950. DOI: 10.1021/acs.jcim.1c00203. View

15.

Domingo J, Nadal M . Human exposure to per- and polyfluoroalkyl substances (PFAS) through drinking water: A review of the recent scientific literature. Environ Res. 2019; 177:108648. DOI: 10.1016/j.envres.2019.108648. View

16.

Kowalska D, Sosnowska A, Bulawska N, Stepnik M, Besselink H, Behnisch P . How the Structure of Per- and Polyfluoroalkyl Substances (PFAS) Influences Their Binding Potency to the Peroxisome Proliferator-Activated and Thyroid Hormone Receptors-An In Silico Screening Study. Molecules. 2023; 28(2). PMC: 9866891. DOI: 10.3390/molecules28020479. View

17.

Shearer J, Callahan C, Calafat A, Huang W, Jones R, Sabbisetti V . Serum Concentrations of Per- and Polyfluoroalkyl Substances and Risk of Renal Cell Carcinoma. J Natl Cancer Inst. 2020; 113(5):580-587. PMC: 8096365. DOI: 10.1093/jnci/djaa143. View

18.

Azhagiya Singam E, Durkin K, La Merrill M, Furlow J, Wang J, Smith M . The vitamin D receptor as a potential target for the toxic effects of per- and polyfluoroalkyl substances (PFASs): An in-silico study. Environ Res. 2022; 217:114832. PMC: 10044465. DOI: 10.1016/j.envres.2022.114832. View

19.

Mukherjee S, Balius T, Rizzo R . Docking validation resources: protein family and ligand flexibility experiments. J Chem Inf Model. 2010; 50(11):1986-2000. PMC: 3058392. DOI: 10.1021/ci1001982. View

20.

Pierozan P, Kosnik M, Karlsson O . High-content analysis shows synergistic effects of low perfluorooctanoic acid (PFOS) and perfluorooctane sulfonic acid (PFOA) mixture concentrations on human breast epithelial cell carcinogenesis. Environ Int. 2023; 172:107746. DOI: 10.1016/j.envint.2023.107746. View